Evidence map›Paper›PMID 25254156›Full record

ArticleSchizophrenia research. Cognition2014

Cognition in schizophrenia: Past, present, and future.

Michael F Green, Philip D Harvey

2 registry-linked trialsAbstract read
In one paragraph

Article in Schizophrenia research. Cognition, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 106 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05105542 phase1completednot on this mapstarted 2021, after this paper: background citation

Muscarinic M1 Receptor Availability and Cognition in Schizophrenia

TypeinterventionalSponsorYale UniversityRan2021 to 2023Enrolled18ConditionsSchizophrenia, Schizoaffective Disorder, HealthyArms11C-EMO - A Novel PET Radiotracer for Muscarinic M1 Receptor, PET Scan
NCT05130853 nacompletednot on this mapstarted 2021, after this paper: background citation

Social Cognition Individualized Activities Lab (SoCIAL) for the Training of Social Cognition and Narrative Enhancement in Patients With Schizophrenia: A Randomized Controlled Study to Assess Efficacy and Generalization to Real-life Functioning

TypeinterventionalSponsorUniversity of Campania Luigi VanvitelliRan2021 to 2022Enrolled48ConditionsSchizophrenia, Schizo Affective DisorderArmsSocial Skills and Neurocognitive Individualized Training (SoCIAL), Treatmment-as-usual
3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia.European psychiatry : the journal of the Association of European Psychiatrists · 2022
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Early efficacy of rTMS intervention at week 2 predicts subsequent responses at week 24 in schizophrenia in a randomized controlled trial.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Michael F GreenSemel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, CA, USA ; Department of Veterans Affairs, Desert Pacific Mental Illness Research, Education, and Clinical Center, Los Angeles, CA, USA.
Philip D HarveyDepartment of Psychiatry, University of Miami Miller School of Medicine, Miami, FL, USA ; Bruce Carter VA Medical Center, Miami, FL, USA.

Funding

EARLY VISUAL PROCESSING IN SCHIZOPHRENIAR01MH043292 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GREEN, MICHAEL F. · 1996 to 2010
$3.5M
Social Cognition Psychometric EvaluationR01MH093432 · NIMH · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI HARVEY, PHILIP D., PENN, DAVID LEWIS · 2012 to 2016
$3.2M
Validation of Measures of real-world outcomeR01MH078775 · NIMH · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI HARVEY, PHILIP D. · 2007 to 2011
$1.7M
NIMH NIH HHS R01 MH043292NIMH NIH HHS R01 MH078775NIMH NIH HHS R01 MH093432
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CognitionHistorySchizophrenia

Identifiers

PMID25254156
PMCPMC4171037

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.